Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BL | Ryan Owen | Chief Executive Officer | 20.08.2026 | Steuer-Abgabe | 31,92 | 2.235 | 71.341 | Form 4 |
| BL | Morgan-Prager Karole | Chief Legal and Administrative | 20.08.2026 | Steuer-Abgabe | 31,92 | 1.063 | 33.931 | Form 4 |
| BL | Morgan-Prager Karole | Chief Legal and Administrative | 20.08.2026 | Steuer-Abgabe | 31,92 | 884 | 28.217 | Form 4 |
| BL | Morgan-Prager Karole | Chief Legal and Administrative | 20.08.2026 | Steuer-Abgabe | 31,92 | 778 | 24.834 | Form 4 |
| BLND | Tkach Oxana | PRINCIPAL ACCOUNTING OFFICER | 17.08.2026 | Verkauf | 1,45 | 21.209 | 30.685 | Form 4 |
| BLND | Haveli Investments, L.P. | Director | 17.08.2026 | Kauf | 1,44 | 17.397 | 25.120 | Form 4 |
| BLKB | Anderson Chad | Executive VP and CFO | 14.08.2026 | Steuer-Abgabe | 46,21 | 589 | 27.218 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 12.08.2026 | Verkauf | 180,57 | 223 | 40.267 | Form 4 |
| BLTE | Chuang Hao-Yuan | Chief Financial Officer | 12.08.2026 | Verkauf | 180,00 | 144 | 25.920 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 12.08.2026 | Verkauf | 180,57 | 223 | 40.267 | Form 4 |
| BLTE | Lin Yu-Hsin | Chief Executive Officer | 12.08.2026 | Verkauf | 180,00 | 142 | 25.560 | Form 4 |
| BLBD | Thau Daniel Mark | Director | 12.08.2026 | Kauf | 64,37 | 350 | 22.530 | Form 4 |
| BLSM | Gordon Carl L | Director | 10.08.2026 | Kauf | 16,00 | 625.000 | 10.000.000 | Form 4 |
| BLSM | Gordon Carl L | Director | 10.08.2026 | Wandlung | — | 1.049.283 | — | Form 4 |
| BLSM | Gordon Carl L | Director | 10.08.2026 | Wandlung | — | 1.039.996 | — | Form 4 |
| BLSM | Orbimed Advisors Llc | Director | 10.08.2026 | Kauf | 16,00 | 625.000 | 10.000.000 | Form 4 |
| BLSM | Orbimed Advisors Llc | Director | 10.08.2026 | Wandlung | — | 1.049.283 | — | Form 4 |
| BLSM | Orbimed Advisors Llc | Director | 10.08.2026 | Wandlung | — | 1.039.996 | — | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 10.08.2026 | Verkauf | 92,86 | 1.417 | 131.583 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 10.08.2026 | Verkauf | 92,86 | 10.000 | 928.600 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 10.08.2026 | Optionsausübung | 2,80 | 10.000 | 28.000 | Form 4 |
| BLKB | Gregoire Kevin P. | EVP, Chief Operating Officer | 06.08.2026 | Verkauf | 45,72 | 5.816 | 265.926 | Form 4 |
| BLKB | Gregoire Kevin P. | EVP, Chief Operating Officer | 06.08.2026 | Verkauf | 45,43 | 16.184 | 735.166 | Form 4 |
| BLND | Thomson Matthew Christopher | Head of Revenue | 05.08.2026 | Verkauf | 2,00 | 15.041 | 30.142 | Form 4 |
| BLKB | Pyburn Bradley L | Director | 03.08.2026 | Zuteilung | — | 7.834 | — | Form 4 |
| BLKB | DeFiore Deneen | Director | 03.08.2026 | Zuteilung | — | 7.834 | — | Form 4 |
| BLKB | Nanney Don Roger | Director | 03.08.2026 | Zuteilung | — | 7.834 | — | Form 4 |
| BLKB | Talvitie Kristian | Director | 03.08.2026 | Zuteilung | — | 7.834 | — | Form 4 |
| BLKB | Leitch Andrew M | Director | 03.08.2026 | Zuteilung | — | 7.834 | — | Form 4 |
| BLK | Fink Laurence | Chairman and CEO | 21.07.2026 | Schenkung | — | 7.852 | — | Form 4 |
| BLDR | O'Brien Matthew Coley | Chief Human Resources Officer | 18.07.2026 | Zuteilung | — | 7.406 | — | Form 4 |
| BLDR | Vaughn Paul | President - West Division | 18.07.2026 | Zuteilung | — | 3.366 | — | Form 4 |
| BLDR | Vance Todd | President - East Division | 18.07.2026 | Zuteilung | — | 3.366 | — | Form 4 |
| BLFS | Werner Sean | Chief Technology Officer | 17.07.2026 | Steuer-Abgabe | 29,15 | 275 | 8.016 | Form 4 |
| BLK | Fink Laurence | Chairman and CEO | 16.07.2026 | Verkauf | 1.080,57 | 1.905 | 2.058.486 | Form 4 |
| BLK | Meade Christopher J. | General Counsel and CLO | 16.07.2026 | Verkauf | 1.102,80 | 2.200 | 2.426.152 | Form 4 |
| BLK | Meade Christopher J. | General Counsel and CLO | 16.07.2026 | Verkauf | 1.101,99 | 15.895 | 17.516.188 | Form 4 |
| BLK | Meade Christopher J. | General Counsel and CLO | 16.07.2026 | Optionsausübung | 513,50 | 18.095 | 9.291.783 | Form 4 |
| BLSH | Wynn Andrew Charles | Director | 10.07.2026 | Zuteilung | — | 2.063 | — | Form 4 |
| BLFS | Wichterman Troy | Chief Financial Officer | 07.07.2026 | Steuer-Abgabe | 27,79 | 844 | 23.455 | Form 4 |
| BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | 07.07.2026 | Steuer-Abgabe | 27,79 | 516 | 14.340 | Form 4 |
| BLFS | Berard Todd | Chief Marketing Officer | 07.07.2026 | Steuer-Abgabe | 27,79 | 293 | 8.142 | Form 4 |
| BLTE | Nathan L Mata | Insider | 22.04.2026 | Verkauf | 170,38 | 1.000 | 170.380 | Form 4 |
| BLTE | Nathan L Mata | Insider | 20.04.2026 | Verkauf | 163,59 | 1.000 | 163.590 | Form 4 |
| BLTE | Nathan L Mata | Insider | 17.04.2026 | Verkauf | 161,63 | 1.000 | 161.630 | Form 4 |
| BLKB | Anderson Chad | Executive VP and CFO | 14.08.2025 | Steuer-Abgabe | 63,18 | 397 | 25.082 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).